Search

everythinglearnresearchcommunity

for

Search:↓

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Postpartum depression is linked to changes in brain chemicals, inflammation, stress, and certain genes, and can potentially be identified by markers like specific steroids, serotonin levels, and vitamin D levels.

Vitamin D is important for skin health and may affect conditions like psoriasis and hair loss, but more research is needed to understand its role fully.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

The document concludes that proper diagnosis and a combination of medical, hair-care, and surgical treatments are important for managing alopecia in black women.

Minoxidil helped bald patient regrow hair.

Sericin hydrogels heal skin wounds well, regrowing hair and glands with less scarring.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Minoxidil use increases facial hair growth in females, more in older users.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

The document concludes that veterinary dermatologists need more experience and a better approach to treating skin diseases in nonhuman primates.

Systemic diseases can cause hair loss, which is often reversible with treatment.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Minoxidil in breast milk may harm nursing infants.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Educators and publishers should focus on teaching racism as the cause of health inequity and ensure fair use of race in materials.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.